1. Visceral metastases in prostate cancer: an underestimated and understudied subgroup;Bourlon;Oncology (Williston Park, NY),2014
2. Visceral disease in castration-resistant prostate cancer;Pezaro;Eur Urol,2014
3. Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer;Fizazi;N Engl J Med,2017
4. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial;James;Lancet,2016
5. Abiraterone for prostate cancer not previously treated with hormone therapy;James;N Engl J Med,2017